(Q50554860)

English

Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.

scientific article published on 12 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Francisco Abad-Santos

8

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Rosario López-Rodríguez

object named as

R Lopez-Rodriguez

1

0 references

author name string

M Trapero-Marugan

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

M J Borque

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

M Roman

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

A Hernandez-Bartolome

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Y Rodriguez-Muñoz

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

S Martin-Vilchez

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

P Muñoz de Rueda

9

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

J R Vidal-Castiñeira

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

L Rodrigo

11

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

J Salmeron

12

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

R Moreno-Otero

13

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

P Sanz-Cameno

14

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

language of work or name

0 references

publication date

12 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

90

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

712-721

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Coordinated Regulation and Widespread Cellular Expression of Interferon-Stimulated Genes (ISG) ISG-49, ISG-54, and ISG-56 in the Central Nervous System after Infection with Distinct Viruses

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Structure and function of a new STAT-induced STAT inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

SNPStats: a web tool for the analysis of association studies.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Hepatitis C and liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.189

21 January 2018

Identifiers

10.1038/CLPT.2011.189

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21993426

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50554860&oldid=1233688967"